Pfizer, Inc. First Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component Pfizer, Inc. (NYSE:PFE) will unveil its latest earnings on Tuesday, May 1, 2012. Pfizer is a global pharmaceutical company which develops and manufactures prescription medications for humans and animals.

Pfizer, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average analyst estimate is for profit of 56 cents per share, a decline of 6.7% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from 57 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 56 cents during the last month. For the year, analysts are projecting net income of $2.25 per share, a decline of 2.6% from last year.

Past Earnings Performance: Last quarter, the company beat estimates by 3 cents, coming in at profit of 50 cents a share versus the estimate of net income of 47 cents a share. It marked the fourth straight quarter of beating estimates.

Investing Insights: What’s the Future of Microsoft’s Stock?

Wall St. Revenue Expectations: On average, analysts predict $15.46 billion in revenue this quarter, a decline of 6.3% from the year-ago quarter. Analysts are forecasting total revenue of $62.15 billion for the year, a decline of 7.8% from last year’s revenue of $67.42 billion.

Analyst Ratings: Analysts are high on the stock, with 15 analysts rating it as a buy, none rating it as a sell and two rating it as a hold.

A Look Back: In the fourth quarter of the last fiscal year, profit fell 50.2% to $1.44 billion (19 cents a share) from $2.89 billion (36 cents a share) the year earlier, but exceeded analyst expectations. Revenue fell 4.6% to $16.75 billion from $17.56 billion.

Key Stats:

The company is looking to get back on track with this earnings announcement after a profit drop last quarter snapped a positive string of results. Net income rose 9.7% in the first quarter of the last fiscal year, 5.5% in the second quarter of the last fiscal year and more than fourfold in the third quarter of the last fiscal year before declining in the fourth quarter of the last fiscal year.

On the top line, the company is looking to rebound after a revenue drop last quarter. Revenue rose 6.3% in the the third quarter of the last fiscal year after dropping in the fourth quarter of the last fiscal year of the last fiscal year.

Stock Price Performance: Between February 28, 2012 and April 25, 2012, the stock price had risen $1.66 (7.8%), from $21.22 to $22.88. The stock price saw one of its best stretches over the last year between March 6, 2012 and March 13, 2012, when shares rose for six straight days, increasing 3.5% (+74 cents) over that span. It saw one of its worst periods between March 30, 2012 and April 13, 2012 when shares fell for 10 straight days, dropping 3.5% (-80 cents) over that span.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Don’t Miss These Additional Hot Stories:

The Procter & Gamble Company Third Quarter Earnings Sneak Peek>>

Apple Pounds Critics into Applesauce>>

Gold & Silver: Ben Bernanke Overshadows FOMC Minutes>>